Quantitative Determination of Olanzapine in Pharmaceutical Preparations by HPLC


  • Kanakapura Basavaiah University of Mysore
  • Anil kumar Urdigere Rangachar University of Mysore
  • Kalsang Tharpa University of Mysore




olanzapine, quantification, HPLC, pharmaceuticals


A new high performance liquid chromatographic (HPLC) method in reverse phase was developed and validated for the determination of olanzapine (OLZ) in pharmaceutical formulations. Optimum separation was achieved in less than 10 min using a reversed phase Intersil ODS column (150 mm Å~ 4.6 mm, i.d., particle size 5 mm), and elution was accomplished using a mobile phase (0.5 mL/min). Detection was carried out using a UV detector set at 271 nm. A rectilinear relationship between mean peak area and concentration of OLZ was observed in the range 10-200 mg/mL, with a detection limit of 3.0 mg/mL and a quantization limit of 8.0 mg/mL. Intra-day and Inter-day precision, and accuracy of the methods have been established according to the current ICH guidelines. The developed method was successfully applied to the determination of OLZ in pharmaceutical formulations. The results were statistically compared with those of the reference method by applying Student’s t-test and F-test. Accuracy, evaluated by means of the spike recovery method, was in the range 97.7-102.3%, with precision (RSD) better than 2%. No interference was observed from the coformulated substances. The method was economical in terms of the time taken and the amount of solvent used.


Download data is not yet available.

Author Biographies

Kanakapura Basavaiah, University of Mysore

Department of Chemistry

Anil kumar Urdigere Rangachar, University of Mysore

Department of Chemistry

Kalsang Tharpa, University of Mysore

Department of Chemistry


1. “The Merck Index”, 12th edn, Merck and Co. Inc, White House Station, NJ, 1997, 1170.
2. Firdous, S.; Aman, T.; Nisa, A. J. Chem. Soc. Pakistan., 2005, 27, 163-167.
3. Gowri, D.S.; Rajendra Kumar, J.M.; Reddy, M.V.V.N. J. Inst. Chem. (India)., 2003, 75, 135-136.
4. Anna, K.; Barbara, S.; Helana, P.; Joanna, S. Anal. Sci., 2006, 22, 829-833.
5. Sivaprasad, K.V.; Rajendra kumar, J.M.; M.V.V.N. Reddy, M.V.V.N.; Prabhakar, G.; Sankar, D.G. Asian J. Chem., 2003, 15, 1127-1130.
6. Jasinska, A.; Nalewajko, E. Anal. Chim. Acta., 2004, 508, 165-170.
7. Xia, X.; Tao, Z. Zhongguo Yiyao Gongye Zazhi., 2004, 35, 46-48.
8. Raggi, M. A.; Casamenti, G.; Mandrioli, R.; Izzo, G.; Kenndler, E. J. Pharm. Biomed. Anal., 2000, 23, 973-981.
9. Shah, Charmy R.; Shah, Nehal J.; Suhagia, Bhanubhai N.; Patel, Natvarlal M. J. AOAC Intl., 2007, 90, 1573-1578.
10. Saxena, V.; Zaheer,Z.; Farooqui, M. Asian J. Chem., 2006, 18, 1212-1222.
11. International Conference on Hormonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use,
ICH Harmonised Tripartite Guideline, “Validation of Analytical Procedures”: Text and Methodology Q2(R 1), Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, London.
12. Shabir, G.A. J. Chromatogr. A. 2003, 987, 57-66.
13. Ermer, J. J. Pharm.Biomed. Anal. 2001, 24, 755-767.






Regular Articles